These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 33051708)
1. Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine. AbouSamra MM; Salama AH; Awad GEA; Mansy SS AAPS PharmSciTech; 2020 Oct; 21(7):283. PubMed ID: 33051708 [TBL] [Abstract][Full Text] [Related]
2. Bilayer mucoadhesive buccal films with prolonged release of ciclopirox olamine for the treatment of oral candidiasis: In vitro development, ex vivo permeation testing, pharmacokinetic and efficacy study in rabbits. Gajdošová M; Vetchý D; Muselík J; Gajdziok J; Juřica J; Vetchá M; Hauptman K; Jekl V Int J Pharm; 2021 Jan; 592():120086. PubMed ID: 33188896 [TBL] [Abstract][Full Text] [Related]
3. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Shaikh KS; Chellampillai B; Pawar AP Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Ciclopirox Olamine after Buccal Administration in Rabbits. Lukášová I; Muselík J; Vetchý D; Gajdziok J; Gajdošová M; Juřica J; Knotek Z; Hauptman K; Jekl V Curr Drug Deliv; 2017; 14(1):99-108. PubMed ID: 27138296 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems. AbouSamra MM; Salama AH J Liposome Res; 2017 Dec; 27(4):324-334. PubMed ID: 27666873 [TBL] [Abstract][Full Text] [Related]
6. A preformulation strategy for the selection of penetration enhancers for a transungual formulation. Palliyil B; Lebo DB; Patel PR AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254 [TBL] [Abstract][Full Text] [Related]
7. Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Rençber S; Karavana SY; Yılmaz FF; Eraç B; Nenni M; Özbal S; Pekçetin Ç; Gurer-Orhan H; Hoşgör-Limoncu M; Güneri P; Ertan G Int J Nanomedicine; 2016; 11():2641-53. PubMed ID: 27358561 [TBL] [Abstract][Full Text] [Related]
8. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159 [TBL] [Abstract][Full Text] [Related]
9. MODELLING AND BIOPHARMACEUTICAL EVALUATION OF CICLOPIROX OLAMINE GELS. Mazurkeviciute A; Ramanauskiene K; Askiene MI; Grigonis A; Briedis V Acta Pol Pharm; 2017 Mar; 74(2):543-549. PubMed ID: 29624259 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and non-toxicity of ciclopirox olamine-loaded liposomes against Cryptococcus neoformans clinical isolates. de Oliveira Kocerginsky P; Dos Santos Soares PH; Lyra HFS; Cadena PG; de Lima-Neto RG; Pontes-Filho NT; Lima-Filho JVM; Costa-Júnior SD; Neves RP; Cavalcanti IMF; Santos-Magalhães NS Braz J Microbiol; 2023 Sep; 54(3):1513-1521. PubMed ID: 37540461 [TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal. Karimunnisa S; Atmaram P Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766 [TBL] [Abstract][Full Text] [Related]
12. Topical antifungal bigels: Formulation, characterization and evaluation. Mazurkeviciute A; Ramanauskiene K; Ivaskiene M; Grigonis A; Briedis V Acta Pharm; 2018 Jun; 68(2):223-233. PubMed ID: 29702483 [TBL] [Abstract][Full Text] [Related]
13. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films. Täuber A; Müller-Goymann CC Int J Pharm; 2015 Jul; 489(1-2):73-82. PubMed ID: 25895717 [TBL] [Abstract][Full Text] [Related]
14. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention. Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis. Clin Ther; 1985; 8(1):41-8. PubMed ID: 2870809 [TBL] [Abstract][Full Text] [Related]
16. Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles. Kammoun AK; Khedr A; Hegazy MA; Almalki AJ; Hosny KM; Abualsunun WA; Murshid SSA; Bakhaidar RB Drug Deliv; 2021 Dec; 28(1):2229-2240. PubMed ID: 34668818 [TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical profile of a clotrimazole nanoemulsion: Evaluation on skin and mucosae as anticandidal agent. Soriano-Ruiz JL; Calpena-Capmany AC; Cañadas-Enrich C; Febrer NB; Suñer-Carbó J; Souto EB; Clares-Naveros B Int J Pharm; 2019 Jan; 554():105-115. PubMed ID: 30395953 [TBL] [Abstract][Full Text] [Related]
18. Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug. Naguib SS; Hathout RM; Mansour S Drug Deliv; 2017 Nov; 24(1):99-108. PubMed ID: 28155540 [TBL] [Abstract][Full Text] [Related]
19. Formulation, Optimization and Evaluation of Novel Ultra-deformable Vesicular Drug Delivery System for an Anti-fungal Drug. Nayak D; Tawale RM; Aranjani JM; Tippavajhala VK AAPS PharmSciTech; 2020 May; 21(5):140. PubMed ID: 32419032 [TBL] [Abstract][Full Text] [Related]
20. Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR. Urbanova M; Gajdosova M; Steinhart M; Vetchy D; Brus J Mol Pharm; 2016 May; 13(5):1551-63. PubMed ID: 27019088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]